Market by Type, Prescription, Therapeutic, Application, End-user, and Geography | Forecast 2021-2028
As per Triton Market Research, the global nasal spray market was valued
at $18.28 billion in 2020 and is expected to reach $40.15 billion by 2028,
growing at a CAGR of 8.47% during the forecast period 2021-2028. Nasal sprays
are used to treat various conditions, including lung diseases, congestion,
sinus infection, allergies, asthma, COPD, allergic rhinitis, depression, and
others.
Report scope can be customized per your requirements. Request For Customization
Triton’s report on nasal spray provides an in-depth insight into the
market. The detailed analysis of the market includes key insights, Porter’s
five forces analysis, market attractiveness index, vendor scorecard, key
strategies, and the impact of COVID-19 on the nasal spray market.
The market is driven by factors such as the emerging intranasal vaccines for COVID-19, rising
acceptance of self-administration of medication, and growing use of nasal
sprays due to simple administration techniques. A nasal spray is a potential
non-invasive and mild option. Moreover, as medication to the site of allergic
irritation, it reduces the possibility of systemic side effects and drug
interactions. In addition, intranasal delivery results in broader protection
due to the presence of nasal-associated lymphoid tissue (NALT). Furthermore,
the nasal route results in cross-protection against viral variant strains such
as influenza. Because nasal sprays or drops are simple to use, cost-effective
options are available. As a result, patients are extensively adopting nasal
sprays globally.
Furthermore, delivering medication to a specified target while excluding
other areas has become a challenge in modern medicine. A variety of substances,
for example, have positive effects on the central nervous system (CNS) but
unfavorable side effects in the periphery. However, intranasal administration
has evolved as a non-invasive technique of delivering medications to the
central nervous system (CNS) with the least peripheral exposure. Furthermore,
nasal spray technology is becoming a promising solution for CNS-related
diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease,
depression, obesity, anxiety, autism spectrum disorders, seizures, drug
addiction, eating disorders, and stroke. For instance, in July 2021, InnarisBio
created intranasal medication delivery technology to improve treatment for
mental health conditions.
However, complications due to the excess use of nasal sprays are negatively affecting the market. Many nasal spray medications are readily available for over-the-counter purchase. But continued use of these drugs may damage the nose, causing breathing problems. Besides, patients who take nasal sprays daily are prone to overdosing. Moreover, excess medicine might eventually create nasal irritation and aggravate their symptoms, leading to a cycle of drug misuse. Furthermore, overuse of nasal sprays can increase the risk of sinus and cause infections, coughing, headaches, and nasal channel swelling.
Key geographies covered in
the global nasal spray market are:
•          North America: United
States and Canada
•          Europe: United Kingdom,
France, Germany, Spain, Italy, Russia, and Rest of Europe
•          Asia-Pacific: China,
Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and
Rest of Asia-Pacific
•          Latin America: Brazil,
Mexico, and Rest of Latin America,
•          Middle East and Africa:
Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle
East & Africa
The segmentation analysis of
the nasal spray market includes:
•          Based on Type:
          o         Decongestion
Nasal Spray
          o         Steroid Nasal Spray
          o         Saltwater Solution/ Saline Nasal Spray
•          Based on Prescription:
          o         Over-the-Counter
          o         Prescribed
•          Based on Therapeutic:
          o         Antihistamine
          o         Nasal
Steroids
          o         Anticholinergic
          o         Mast Cell Inhibitor
•          Based on Application:
          o         Nasal Congestion
          o         Allergic and Non-Allergic Rhinitis
          o         Vaccination
          o         CNS Disorders
          o         Other Applications
•          Based on End-user:
          o         Home Care Setting
          o         ASC/Clinics
          o         Pharmacy
          o         Hospital
          o         Other End-Users
The major companies in the nasal spray market
are Johnson and Johnson, Apotex Inc, Sun Pharmaceuticals Industries Ltd,
Sanotize Research and Development, Akorn, Pfizer Inc, Proctor and Gamble Co,
Bharat Biotech, Allergan, Novartis International AG, Catalent Inc, Teva
Pharmaceutical Industries Ltd, Viatris, Cipla Limited, and GlaxoSmithKline.Â
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. GLOBAL
NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. GLOBAL
NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. GLOBAL
NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. GLOBAL
NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. GLOBAL
NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER
END-USERS
8. GLOBAL
NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY TYPE
8.1.2. MARKET
BY PRESCRIPTION
8.1.3. MARKET
BY THERAPEUTIC
8.1.4. MARKET
BY APPLICATION
8.1.5. MARKET
BY END-USER
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.2. CANADA
8.2. EUROPE
8.2.1. MARKET
BY TYPE
8.2.2. MARKET
BY PRESCRIPTION
8.2.3. MARKET
BY THERAPEUTIC
8.2.4. MARKET
BY APPLICATION
8.2.5. MARKET
BY END-USER
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. UNITED
KINGDOM
8.2.6.2. GERMANY
8.2.6.3. FRANCE
8.2.6.4. SPAIN
8.2.6.5. ITALY
8.2.6.6. RUSSIA
8.2.6.7. REST
OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY TYPE
8.3.2. MARKET
BY PRESCRIPTION
8.3.3. MARKET
BY THERAPEUTIC
8.3.4. MARKET
BY APPLICATION
8.3.5. MARKET
BY END-USER
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.2. JAPAN
8.3.6.3. INDIA
8.3.6.4. SOUTH
KOREA
8.3.6.5. ASEAN
COUNTRIES
8.3.6.6. AUSTRALIA
& NEW ZEALAND
8.3.6.7. REST
OF ASIA-PACIFIC
8.4. LATIN
AMERICA
8.4.1. MARKET
BY TYPE
8.4.2. MARKET
BY PRESCRIPTION
8.4.3. MARKET
BY THERAPEUTIC
8.4.4. MARKET
BY APPLICATION
8.4.5. MARKET
BY END-USER
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. BRAZIL
8.4.6.2. MEXICO
8.4.6.3. REST
OF LATIN AMERICA
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY TYPE
8.5.2. MARKET
BY PRESCRIPTION
8.5.3. MARKET
BY THERAPEUTIC
8.5.4. MARKET
BY APPLICATION
8.5.5. MARKET
BY END-USER
8.5.6. COUNTRY
ANALYSIS
8.5.6.1. UNITED
ARAB EMIRATES
8.5.6.2. SAUDI
ARABIA
8.5.6.3. TURKEY
8.5.6.4. SOUTH
AFRICA
8.5.6.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL NASAL SPRAY
MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: GLOBAL NASAL SPRAY
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL NASAL SPRAY
MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL NASAL SPRAY
MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL NASAL SPRAY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL NASAL SPRAY
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL NASAL SPRAY
MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 15: EUROPE NASAL SPRAY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE NASAL SPRAY
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17: EUROPE NASAL SPRAY
MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE NASAL SPRAY
MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE NASAL SPRAY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE NASAL SPRAY
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 27: LATIN AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 33: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 34: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 35: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 36: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND
AFRICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: GLOBAL NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: GLOBAL NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
4: GLOBAL NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE
5: GLOBAL NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY,
2021-2028 (IN $ MILLION)
FIGURE
6: GLOBAL NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: GLOBAL NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)
FIGURE
8: GLOBAL NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: GLOBAL NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: GLOBAL NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)
FIGURE
11: GLOBAL NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)
FIGURE
12: GLOBAL NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)
FIGURE
13: GLOBAL NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)
FIGURE
14: GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: GLOBAL NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)
FIGURE
16: GLOBAL NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028
(IN $ MILLION)
FIGURE
17: GLOBAL NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: GLOBAL NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE
19: GLOBAL NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
20: GLOBAL NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: GLOBAL NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)
FIGURE
22: GLOBAL NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: GLOBAL NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: GLOBAL NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: GLOBAL NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
26: GLOBAL NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: UNITED STATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: CANADA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: UNITED KINGDOM NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
30: GERMANY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
31: FRANCE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
32: SPAIN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
33: ITALY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
34: RUSSIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
35: REST OF EUROPE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
36: CHINA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
37: JAPAN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
38: INDIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
39: SOUTH KOREA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
40: ASEAN COUNTRIES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
41: AUSTRALIA & NEW ZEALAND NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
42: REST OF ASIA-PACIFIC NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
43: BRAZIL NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
44: MEXICO NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
45: REST OF LATIN AMERICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
46: UNITED ARAB EMIRATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
47: SAUDI ARABIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
48: TURKEY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
49: SOUTH AFRICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
50: REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET 2021-2028 (IN $
MILLION)